TRDA
Entrada Therapeutics Inc
5.40$
-5.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -160.9% | – | – | – | – | – | – | – | – | |
| – | -11.8% | +26.9% | -2.6% | +3.0% | +5.9% | -4.6% | +9.3% | +19.0% | -326.4% | – | +4.5% | – | |
| – | +13.1% | -2.8% | +23.8% | +5.1% | -3.3% | +8.2% | -0.8% | +1.3% | -14.8% | +8.9% | +8.6% | – | |
| – | – | -1,848.9% | – | – | – | – | – | +20.3% | -77.0% | -397.0% | – | – | |
| – | -32.6% | -14.1% | +24.8% | -38.9% | -0.6% | +80.2% | -76.0% | -37.8% | +21.1% | -78.7% | -75.0% | – | |
| – | – | +37.3% | -193.3% | +240.1% | – | -91.0% | +606.6% | +45.3% | -40.7% | -7.3% | +103.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +87.5% | -70.1% | +49,107.3% | -100.0% | – | -75.0% | -3.7% | -97.6% | +2,300.0% | -47.9% | +250.0% | – | |
| – | – | -94.7% | +13,906.8% | -191.8% | – | -244.1% | – | +347.9% | -113.9% | – | – | – | |
| – | – | – | – | -164.2% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.